The global Point of Care Molecular Diagnostics was valued at USD 883.5 Million in 2020 and is expected to reach USD 2,530.4 Million by the year 2028, at a CAGR of 13.9%.
The global Point of Care Molecular Diagnostics was valued at USD 883.5 Million in 2020 and is expected to reach USD 2,530.4 Million by the year 2028, at a CAGR of 13.9%.